Literature DB >> 20351341

Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling.

Roxanna A Irani1, Yujin Zhang, Cissy Chenyi Zhou, Sean C Blackwell, M John Hicks, Susan M Ramin, Rodney E Kellems, Yang Xia.   

Abstract

Preeclampsia is a prevalent life-threatening hypertensive disorder of pregnancy for which the pathophysiology remains largely undefined. Recently, a circulating maternal autoantibody, the angiotensin II type I (AT(1)) receptor agonistic autoantibody (AA), has emerged as a contributor to disease features. Increased circulating maternal tumor necrosis factor alpha (TNF-alpha) is also associated with the disease; however, it is unknown whether this factor directly contributes to preeclamptic symptoms. Here we report that this autoantibody increases the proinflammatory cytokine TNF-alpha in the circulation of AT(1)-AA-injected pregnant mice but not in nonpregnant mice. Coinjection of AT(1)-AA with a TNF-alpha neutralizing antibody reduced cytokine availability in AT(1)-AA-injected pregnant mice. Moreover, TNF-alpha blockade in AT(1)-AA-injected pregnant mice significantly attenuated the key features of preeclampsia. Autoantibody-induced hypertension was reduced from 131+/-4 to 110+/-4 mm Hg, and proteinuria was reduced from 212+/-25 to 155+/-23 microg of albumin per milligram of creatinine (both P<0.05). Injection of AT(1)-AA increased the serum levels of circulating soluble fms-like tyrosine kinase 1 and soluble endoglin (34.1+/-5.1, 2.4+/-0.3 ng/mL, respectively) and coinjection with the TNF-alpha blocker significantly reduced their levels (21.7+/-3.4 and 1.2+/-0.4 ng/mL, respectively). Renal damage and placental abnormalities were also decreased by TNF-alpha blockade. Lastly, the elevated circulating TNF-alpha in preeclamptic patients is significantly correlated with the AT(1)-AA bioactivity in our patient cohort. Similarly, the autoantibody, through AT(1) receptor-mediated TNF-alpha induction, contributed to increased soluble fms-like tyrosine kinase 1, soluble endoglin secretion, and increased apoptosis in cultured human villous explants. Overall, AT(1)-AA is a novel candidate that induces TNF-alpha, a cytokine that may play an important pathogenic role in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351341      PMCID: PMC3380607          DOI: 10.1161/HYPERTENSIONAHA.110.150540

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  52 in total

Review 1.  Latest advances in understanding preeclampsia.

Authors:  Christopher W Redman; Ian L Sargent
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

2.  Circulating levels of immunoreactive cytokines in women with preeclampsia.

Authors:  K P Conrad; T M Miles; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1998-08       Impact factor: 3.886

3.  Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion.

Authors:  Sol M Bobst; Mary-Clare Day; Larry C Gilstrap; Yang Xia; Rodney E Kellems
Journal:  Am J Hypertens       Date:  2005-03       Impact factor: 2.689

4.  Angiotensin II induces apoptosis in human and rat alveolar epithelial cells.

Authors:  R Wang; A Zagariya; O Ibarra-Sunga; C Gidea; E Ang; S Deshmukh; G Chaudhary; J Baraboutis; G Filippatos; B D Uhal
Journal:  Am J Physiol       Date:  1999-05

5.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

Authors:  G Wallukat; V Homuth; T Fischer; C Lindschau; B Horstkamp; A Jüpner; E Baur; E Nissen; K Vetter; D Neichel; J W Dudenhausen; H Haller; F C Luft
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  Angiotensin II induces TNF production by the thick ascending limb: functional implications.

Authors:  N R Ferreri; B A Escalante; Y Zhao; S J An; J C McGiff
Journal:  Am J Physiol       Date:  1998-01

7.  Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

Authors:  S Jovinge; A Hamsten; P Tornvall; A Proudler; P Båvenholm; C G Ericsson; I Godsland; U de Faire; J Nilsson
Journal:  Metabolism       Date:  1998-01       Impact factor: 8.694

8.  Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.

Authors:  X Li; M Shams; J Zhu; A Khalig; M Wilkes; M Whittle; N Barnes; A Ahmed
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

9.  Interleukin-12 augments cytolytic activity of peripheral and decidual lymphocytes against choriocarcinoma cell lines and primary culture human placental trophoblasts.

Authors:  S Hayakawa; N Nagai; T Kanaeda; M Karasaki-Suzuki; M Ishii; F Chishima; K Satoh
Journal:  Am J Reprod Immunol       Date:  1999-05       Impact factor: 3.886

10.  Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.

Authors:  M Ruiz-Ortega; C Bustos; M A Hernández-Presa; O Lorenzo; J J Plaza; J Egido
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

View more
  40 in total

1.  A2B adenosine receptor-mediated induction of IL-6 promotes CKD.

Authors:  Yingbo Dai; Weiru Zhang; Jiaming Wen; Yujin Zhang; Rodney E Kellems; Yang Xia
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 2.  Molecular Mechanisms of Preeclampsia.

Authors:  Tammy Hod; Ana Sofia Cerdeira; S Ananth Karumanchi
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-20       Impact factor: 6.915

3.  Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.

Authors:  Athar H Siddiqui; Roxanna A Irani; Yujin Zhang; Yingbo Dai; Sean C Blackwell; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2010-12-23       Impact factor: 2.689

Review 4.  Elucidating immune mechanisms causing hypertension during pregnancy.

Authors:  Babbette LaMarca; Denise Cornelius; Kedra Wallace
Journal:  Physiology (Bethesda)       Date:  2013-07

5.  Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.

Authors:  Cissy Chenyi Zhou; Roxanna A Irani; Yingbo Dai; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

6.  RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models.

Authors:  Nadine Haase; Donald J Foster; Mark W Cunningham; Julia Bercher; Tuyen Nguyen; Svetlana Shulga-Morskaya; Stuart Milstein; Sarfraz Shaikh; Jeff Rollins; Michaela Golic; Florian Herse; Kristin Kräker; Ivo Bendix; Meray Serdar; Hanna Napieczynska; Arnd Heuser; Alexandra Gellhaus; Kristin Thiele; Gerd Wallukat; Dominik N Müller; Babbette LaMarca; Ralf Dechend
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

7.  Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study.

Authors:  Piya Chaemsaithong; Roberto Romero; Adi L Tarca; Steven J Korzeniewski; Alyse G Schwartz; Jezid Miranda; Ahmed I Ahmed; Zhong Dong; Sonia S Hassan; Lami Yeo; Tinnakorn Tinnakorn
Journal:  J Matern Fetal Neonatal Med       Date:  2014-09-29

8.  GPCRs as potential therapeutic targets in preeclampsia.

Authors:  Jt McGuane; Kp Conrad
Journal:  Drug Discov Today Dis Models       Date:  2012-07-12

Review 9.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 10.  Renin-angiotensin system in pre-eclampsia: everything old is new again.

Authors:  Julia J Spaan; Mark A Brown
Journal:  Obstet Med       Date:  2012-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.